Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - 99 |
| Updated: | 12/19/2018 |
| Start Date: | July 3, 2012 |
| End Date: | April 18, 2024 |
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation at the University of Texas Southwestern Medical Center
Registry database repository for determining clinical outcomes primarily of patients who have
received or have been evaluated for radiation treatment in either the definitive or
palliative setting for both malignant and benign etiologies.
To compare the outcomes with National Cancer Data Base (NCDB) of the American College of
Surgeon(ACS).
received or have been evaluated for radiation treatment in either the definitive or
palliative setting for both malignant and benign etiologies.
To compare the outcomes with National Cancer Data Base (NCDB) of the American College of
Surgeon(ACS).
Investigator will retrospectively collect and evaluate information from patients with cancer
or benign etiologies to improve future clinical outcomes and help identify prospective
outcomes study questions. This information will include patients' name, medical record
number, medical history, diagnosis, treatment, laboratory test results, diagnostic test
results, pathology reports, therapeutic and nontherapeutic results, surgical results,
radiology results, radiation therapy details (dose, techniques, toxicity), concurrent use of
chemotherapy/systemic therapy, quality of life outcomes,cachexia status, and primarily last
follow-up data. All information will be collected after their standard of care visits.
or benign etiologies to improve future clinical outcomes and help identify prospective
outcomes study questions. This information will include patients' name, medical record
number, medical history, diagnosis, treatment, laboratory test results, diagnostic test
results, pathology reports, therapeutic and nontherapeutic results, surgical results,
radiology results, radiation therapy details (dose, techniques, toxicity), concurrent use of
chemotherapy/systemic therapy, quality of life outcomes,cachexia status, and primarily last
follow-up data. All information will be collected after their standard of care visits.
Inclusion Criteria:
Any patient who received or was potentially evaluated for radiotherapy since 2000 for
benign or malignant etiologies in the definitive or palliative setting.
Patients with comparatively similar diagnosis and disease status at UTSW, but electing not
to undergo radiation therapy, treated with surgical or systemic therapy, or best supportive
care, being followed by an oncology specialist at UT Southwestern Medical Center will also
be eligible for evaluation. -
Exclusion Criteria:
We found this trial at
1
site
Click here to add this to my saved trials
